Comparing Model N (MODN) & Cardlytics (CDLX)

Share on StockTwits

Model N (NYSE:MODN) and Cardlytics (NASDAQ:CDLX) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Valuation & Earnings

This table compares Model N and Cardlytics’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Model N $131.17 million 3.61 -$39.54 million ($0.83) -18.24
Cardlytics $130.37 million 3.17 -$19.64 million ($8.02) -2.54

Cardlytics has lower revenue, but higher earnings than Model N. Model N is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Model N and Cardlytics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Model N -21.89% -61.62% -14.54%
Cardlytics N/A N/A N/A

Insider and Institutional Ownership

68.7% of Model N shares are held by institutional investors. Comparatively, 49.7% of Cardlytics shares are held by institutional investors. 18.9% of Model N shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Model N and Cardlytics, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Model N 0 2 5 0 2.71
Cardlytics 0 1 5 0 2.83

Model N currently has a consensus price target of $23.20, indicating a potential upside of 53.24%. Cardlytics has a consensus price target of $24.40, indicating a potential upside of 19.67%. Given Model N’s higher possible upside, equities research analysts plainly believe Model N is more favorable than Cardlytics.

Model N Company Profile

Model N, Inc. provides revenue management cloud solutions for the life sciences, technology, and manufacturing companies. The company's cloud-based revenue management solutions include Revenue Cloud for Pharma, Revenue Cloud for Med Tech, Revenue Cloud for High Tech, and Revenue Cloud. It develops software applications, such as managed care and government pricing for life science companies; and channel incentives for technology companies. The company also offers revenue management processes, such as pricing, contracting, rebates, incentives, channel management, and regulatory compliance. In addition, Model N, Inc. provides implementation, managed, strategic, and customer support services. It primarily serves large and mid-sized organizations worldwide through its direct sales force. Model N, Inc. was founded in 1999 and is headquartered in San Mateo, California, with additional offices in the United States, India, and Switzerland.

Cardlytics Company Profile

Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Receive News & Ratings for Model N Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Model N and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Horizonte Minerals  Hits New 1-Year Low at $0.03
Horizonte Minerals Hits New 1-Year Low at $0.03
Avivagen  Reaches New 12-Month Low at $0.42
Avivagen Reaches New 12-Month Low at $0.42
FrankyWillCoin  Price Reaches $0.0034 on Exchanges
FrankyWillCoin Price Reaches $0.0034 on Exchanges
Bitcoin Zero Price Tops $0.0239
Bitcoin Zero Price Tops $0.0239
Physicians Realty Trust  Expected to Post Quarterly Sales of $103.44 Million
Physicians Realty Trust Expected to Post Quarterly Sales of $103.44 Million
Analysts Set $17.55 Target Price for GreenTree Hospitality Group Ltd –
Analysts Set $17.55 Target Price for GreenTree Hospitality Group Ltd –


© 2006-2018 Ticker Report